FR2879604B1 - FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF - Google Patents

FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF

Info

Publication number
FR2879604B1
FR2879604B1 FR0413711A FR0413711A FR2879604B1 FR 2879604 B1 FR2879604 B1 FR 2879604B1 FR 0413711 A FR0413711 A FR 0413711A FR 0413711 A FR0413711 A FR 0413711A FR 2879604 B1 FR2879604 B1 FR 2879604B1
Authority
FR
France
Prior art keywords
citrulin
rhe
fibrin
antibodies
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0413711A
Other languages
French (fr)
Other versions
FR2879604A1 (en
Inventor
Olivier Serre
Mireille Sebbag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0413711A priority Critical patent/FR2879604B1/en
Application filed by Biomerieux SA filed Critical Biomerieux SA
Priority to US11/577,674 priority patent/US8207299B2/en
Priority to AT05815291T priority patent/ATE401338T1/en
Priority to JP2007538475A priority patent/JP5060300B2/en
Priority to DE602005008277T priority patent/DE602005008277D1/en
Priority to PCT/FR2005/002736 priority patent/WO2006048556A1/en
Priority to ES05815291T priority patent/ES2310853T3/en
Priority to EP05815291A priority patent/EP1814901B1/en
Publication of FR2879604A1 publication Critical patent/FR2879604A1/en
Application granted granted Critical
Publication of FR2879604B1 publication Critical patent/FR2879604B1/en
Priority to US13/489,072 priority patent/US9249208B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
FR0413711A 2004-11-04 2004-12-22 FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF Active FR2879604B1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0413711A FR2879604B1 (en) 2004-12-22 2004-12-22 FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF
AT05815291T ATE401338T1 (en) 2004-11-04 2005-11-03 CITRULLINE PEPTIDES DERIVED FROM FIBRIN RECOGNIZED BY AUTOANTIBODIES SPECIFIC TO RHEUMATOID ARTHRITIS AND THE USE THEREOF
JP2007538475A JP5060300B2 (en) 2004-11-04 2005-11-03 Fibrin-derived citrulline peptides recognized by rheumatoid arthritis-specific autoantibodies and uses thereof
DE602005008277T DE602005008277D1 (en) 2004-11-04 2005-11-03 CITRULLINPEPTIDES DERIVED FROM FIBRIN RECOGNIZED BY RHEUMATOID ARTHRITIS SPECIFIC AUTOANTIC BODIES AND THEIR USE
US11/577,674 US8207299B2 (en) 2004-11-04 2005-11-03 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof
PCT/FR2005/002736 WO2006048556A1 (en) 2004-11-04 2005-11-03 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof
ES05815291T ES2310853T3 (en) 2004-11-04 2005-11-03 CITRULINED PEPTIDES DERIVED FROM FIBRINE RECOGNIZED BY SPECIFIC SELF-AUTHORTIC BODIES OF REUMATOID POLYARTHRITIS AND USES OF THE SAME.
EP05815291A EP1814901B1 (en) 2004-11-04 2005-11-03 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof
US13/489,072 US9249208B2 (en) 2004-11-04 2012-06-05 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0413711A FR2879604B1 (en) 2004-12-22 2004-12-22 FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF

Publications (2)

Publication Number Publication Date
FR2879604A1 FR2879604A1 (en) 2006-06-23
FR2879604B1 true FR2879604B1 (en) 2010-08-13

Family

ID=34952648

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0413711A Active FR2879604B1 (en) 2004-11-04 2004-12-22 FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF

Country Status (1)

Country Link
FR (1) FR2879604B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2307421B1 (en) * 2007-04-30 2009-09-28 Consejo Superiorde Investigaciones Cientificas (Csic) CITRUINATED FIBRINE-FILAGRINE CHEMERIC POLYPEPTIDE CAPABLE OF DETECTING ANTIBODIES GENERATED IN REUMATOID ARTHRITIS.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795735B1 (en) * 1999-07-01 2001-09-07 Univ Toulouse CITRULLIN FIBRIN DERIVATIVES AND THEIR USE FOR DIAGNOSIS OR TREATMENT OF RHUMATOID POLYARTHRITIS
JP4181874B2 (en) * 2000-12-12 2008-11-19 ファイブレックス メディカル リサーチ アンド デベロップメント ゲーエムベーハー Use for preparing peptides and / or proteins and their therapeutic and / or prophylactic pharmaceutical ingredients
US6908899B2 (en) * 2001-08-17 2005-06-21 U.S. Dept. Of Veterans Affairs Pro-inflammatory fibrinopeptide
NL1019540C2 (en) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Method for detecting autoantibodies from patients suffering from rheumatoid arthritis, peptide and assay kit.

Also Published As

Publication number Publication date
FR2879604A1 (en) 2006-06-23

Similar Documents

Publication Publication Date Title
DE602005022897D1 (en) Piperidinylamino-THIENOÄ2,3-DT-pyrimidine
EA200702643A1 (en) TWEAK ANTIBODIES
NO20052559D0 (en) In-line cyclone separator.
DE502005007723D1 (en) 18-METHYL-19-NOR-17-pregn-4-ene-21,17-carbolactone,
DE602006011631D1 (en) packaging system
NL1025902A1 (en) Packaging.
DK1745009T3 (en) Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
ATE378256T1 (en) IMPROVED PACKAGING
DE602005007364D1 (en) cyclic peptides,
FI20061034A (en) Two-stage compression system
DE60305332D1 (en) IMIDAZOi1,2-AöPYRIDINE
NL1031705A1 (en) Amino acid derivatives.
NL1031384A1 (en) Substituted aryl-1,4-pyrazine derivatives.
DE502005002048D1 (en) NARROW SIDE-TO-MEASURED WEIGHING SYSTEM
ITMI20050051A1 (en) POLY-9-ORGANIC PHOTODIODIO DIOTTIL-FLUORENE
FR2879604B1 (en) FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF
FR2877345B1 (en) FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF
DK1720557T3 (en) Fast-soluble, flavor-masked tablet
NO20081069L (en) Dynamic, application-expanding technology
DE602004019824D1 (en) MODIFIED ETHYLENEDIAMIN N, N'-DIBERNIC ACID: ETHYLENEDIAMINE LYASE
ES1055317Y (en) SELF-TRANSPORTABLE SCENARIO.
ES1058072Y (en) TOWEL-ANTI-WIND BAG.
ES1057641Y (en) FOLDING BOTTLE.
ES1056686Y (en) PACKABLE PACKAGING.
ES1060423Y (en) IMPROVED BALANCE RECOVERY BAG.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

RM Correction of a material error

Effective date: 20220218

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20